Singaporean Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Results

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

2 companies

Haw Par

Market Cap: S$2.7b

Manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally.

H02

S$12.30

1.8%

26.3%

Hyphens Pharma International

Market Cap: S$83.4m

Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.

1J5

S$0.28

3.8%

1.9%